V. Roussel‐Robert

550 total citations
18 papers, 337 citations indexed

About

V. Roussel‐Robert is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, V. Roussel‐Robert has authored 18 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 5 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in V. Roussel‐Robert's work include Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). V. Roussel‐Robert is often cited by papers focused on Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). V. Roussel‐Robert collaborates with scholars based in France, Sweden and United Kingdom. V. Roussel‐Robert's co-authors include Jenny Goudemand, Hérvè Chambost, Annie Borel‐Derlon, Ségolène Claeyssens‐Donadel, Benoît Guillet, Christine Vinciguerra, Roseline d’Oiron, Chantal Rothschild, V. Goulet and Thierry Calvez and has published in prestigious journals such as Blood, European Journal of Pharmacology and British Journal of Haematology.

In The Last Decade

V. Roussel‐Robert

18 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Roussel‐Robert France 10 299 69 46 44 31 18 337
A. Tuinenburg Netherlands 9 322 1.1× 114 1.7× 21 0.5× 35 0.8× 102 3.3× 11 400
C. M. Kessler United States 10 340 1.1× 97 1.4× 34 0.7× 33 0.8× 24 0.8× 10 389
Connie Duckers Netherlands 6 286 1.0× 80 1.2× 16 0.3× 23 0.5× 38 1.2× 6 321
Chiara Biasoli Italy 10 356 1.2× 89 1.3× 26 0.6× 57 1.3× 12 0.4× 26 386
Michael Desmond Creagh United Kingdom 8 115 0.4× 19 0.3× 19 0.4× 28 0.6× 14 0.5× 10 170
Iván Murrieta-Álvarez Mexico 8 70 0.2× 20 0.3× 15 0.3× 29 0.7× 13 0.4× 33 166
Francesca Stufano Italy 9 299 1.0× 34 0.5× 76 1.7× 7 0.2× 85 2.7× 16 329
Berntorp Sweden 7 231 0.8× 91 1.3× 23 0.5× 22 0.5× 10 0.3× 8 278
Pierangelo Spedini Italy 7 152 0.5× 17 0.2× 40 0.9× 10 0.2× 27 0.9× 8 210
SJ Koppelman 5 299 1.0× 71 1.0× 19 0.4× 21 0.5× 17 0.5× 9 321

Countries citing papers authored by V. Roussel‐Robert

Since Specialization
Citations

This map shows the geographic impact of V. Roussel‐Robert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Roussel‐Robert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Roussel‐Robert more than expected).

Fields of papers citing papers by V. Roussel‐Robert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Roussel‐Robert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Roussel‐Robert. The network helps show where V. Roussel‐Robert may publish in the future.

Co-authorship network of co-authors of V. Roussel‐Robert

This figure shows the co-authorship network connecting the top 25 collaborators of V. Roussel‐Robert. A scholar is included among the top collaborators of V. Roussel‐Robert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Roussel‐Robert. V. Roussel‐Robert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Faille, Dorothée, Cécile Lavenu‐Bombled, Dominique Lasne, et al.. (2024). Perioperative management and neuraxial analgesia in women with factor XI deficiency (<60 IU/dL): a French multicenter observational study of 314 pregnancies. Research and Practice in Thrombosis and Haemostasis. 8(4). 102462–102462. 1 indexed citations
2.
Trossaërt, Marc, V. Chamouard, Christine Biron‐Andréani, et al.. (2023). Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders. European Journal Of Haematology. 110(6). 584–601. 17 indexed citations
3.
4.
5.
Roussel‐Robert, V., et al.. (2022). A case of Epstein–Barr virus‐associated smooth muscle tumor of the posterior interosseous nerve mimicking schwannoma. Neuropathology. 42(1). 52–57. 1 indexed citations
6.
Roussel‐Robert, V., et al.. (2021). The Hemarthrosis-Simulating Knee Model: A Useful Tool for Individualized Education in Patients with Hemophilia (GEFACET Study). Journal of Blood Medicine. Volume 12. 133–138. 3 indexed citations
7.
Duchemin, Jérôme, Élise Sourdeau, V. Roussel‐Robert, et al.. (2020). Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study. European Journal of Pharmacology. 891. 173764–173764. 2 indexed citations
8.
Chatron, Nicolas, Hérvè Chambost, Ségolène Claeyssens‐Donadel, et al.. (2017). Molecular cytogenetic characterization of five F8 complex rearrangements: utility for haemophilia A genetic counselling. Haemophilia. 23(4). e316–e323. 9 indexed citations
9.
Raucourt, Emmanuelle de, V. Roussel‐Robert, & Eva Zetterberg. (2015). Prevention and treatment of atherosclerosis in haemophilia – how to balance risk of bleeding with risk of ischaemic events. European Journal Of Haematology. 94(s77). 23–29. 12 indexed citations
10.
Calvez, Thierry, Hérvè Chambost, Ségolène Claeyssens‐Donadel, et al.. (2014). Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A. Blood. 124(23). 3398–3408. 108 indexed citations
11.
d’Oiron, Roseline, Virginie Demiguel, Annie Borel‐Derlon, et al.. (2011). Environmental Risk Factors of Inhibitor in Mild/Moderate Hemophilia A Patients Included in the FranceCoag Network. Blood. 118(21). 1213–1213. 1 indexed citations
12.
13.
Borel‐Derlon, Annie, Augusto B. Federici, V. Roussel‐Robert, et al.. (2007). Treatment of severe von Willebrand disease with a high‐purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients. Journal of Thrombosis and Haemostasis. 5(6). 1115–1124. 83 indexed citations
14.
Bérezné, A., Natalie Stieltjes, Luís Teixeira, et al.. (2006). Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases. Transfusion Medicine. 16(3). 209–212. 19 indexed citations
15.
d’Oiron, Roseline, J. Reynaud, Kathelijne Peerlinck, et al.. (2006). Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors. Seminars in Hematology. 43(1 Suppl 1). S3–S9. 18 indexed citations
16.
Stieltjes, Natalie, V. Roussel‐Robert, Arielle R. Rosenberg, et al.. (2004). Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus. British Journal of Haematology. 125(6). 769–776. 17 indexed citations
17.
Stieltjes, Natalie, Carmen Altisent, Günter Auerswald, et al.. (2004). Continuous infusion of B‐domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience. Haemophilia. 10(5). 452–458. 21 indexed citations
18.
Roussel‐Robert, V., M.‐F. Torchet, Fanny Legrand, C. Rothschild, & Natalie Stieltjes. (2003). Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients. Journal of Thrombosis and Haemostasis. 1(11). 2450–2451. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Tuinenburg Breakdown of academic impact, for papers by C. M. Kessler Breakdown of academic impact, for papers by Connie Duckers Breakdown of academic impact, for papers by Chiara Biasoli Breakdown of academic impact, for papers by Michael Desmond Creagh Breakdown of academic impact, for papers by Iván Murrieta-Álvarez Breakdown of academic impact, for papers by Francesca Stufano Breakdown of academic impact, for papers by Berntorp Breakdown of academic impact, for papers by Pierangelo Spedini Breakdown of academic impact, for papers by SJ Koppelman
Rankless by CCL
2026